Resilience Conference: Patient Reported Outcomes in Research and the revolution of AI
Discover with Prof. di Maio & Prof. Massard how Patient Reported Outcomes (PROs) are becoming key to include QoL as endpoints in phase III oncology trials and the paradigm shift in early-phase trials using PROs for dose optimization.
November 18, 2025
15 minutes
Discover in this conference how Patient Reported Outcomes (PROs) are transforming oncology research.
Learn with :
- Professor Massimo di Maio the Importance of PROs in Phase III Clinical Trials: Integrating Quality of Life (QoL) as a key endpoint in oncology trials.
- Professor Christophe Massard the paradigm Shift in Early-Phase Trials: The use of PROs for dose optimization in early-phase trials, specifically through the Project Optimus approach.
Register to access the conference replay.
Speakers:
Prof. Massimo di Maio
Medical Oncologist — Head of the Medical Oncology Unit at Molinette Hospital — Professor at Turin's University — President-elect of AIOM
Turin, Italy
Pr. Christophe Massard
Oncologue médical, Chef du Département de l'Innovation Thérapeutique et des Essais Précoces (DITEP)
Gustave Roussy
.png)
